Cigna Group [CI] stock prices are down -0.91% to $341.49 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CI shares have gain 2.67% over the last week, with a monthly amount drifted -0.87%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cigna Group [NYSE: CI] stock has seen the most recent analyst activity on May 30, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $388. Previously, Barclays started tracking the stock with Overweight rating on March 06, 2024, and set its price target to $393. On February 05, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $354 on the stock. Cantor Fitzgerald upgraded its rating to a Overweight and increased its price target to $372 on February 05, 2024. Deutsche Bank upgraded its rating to a Buy and raised its price target to $370 on February 01, 2024. Bernstein upgraded its rating to Outperform for this stock on January 04, 2024, and upped its price target to $372. In a note dated December 11, 2023, Jefferies upgraded an Buy rating on this stock and boosted its target price from $335 to $341.
The stock price of Cigna Group [CI] has been fluctuating between $248.86 and $365.71 over the past year. Currently, Wall Street analysts expect the stock to reach $315.05 within the next 12 months. Cigna Group [NYSE: CI] shares were valued at $341.49 at the most recent close of the market. An investor can expect a potential drop of -7.74% based on the average CI price forecast.
Analyzing the CI fundamentals
The Cigna Group [NYSE:CI] reported sales of 204.15B for trailing twelve months, representing a surge of 19.28%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 338.90 points at the first support level, and at 336.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 344.41, and for the 2nd resistance point, it is at 347.32.
Ratios To Look Out For
It’s worth pointing out that Cigna Group [NYSE:CI]’s Current Ratio is 0.83. Considering the valuation of this stock, the price to sales ratio is 0.48, the price to book ratio is 2.36 and price to earnings (TTM) ratio is 28.03.
Transactions by insiders
Recent insider trading involved Eder Noelle K,, that happened on May 14 ’24 when 10700.0 shares were sold. SVP Tax & Chief Acct. Officer, Agoglia Hoeltzel Mary T completed a deal on May 14 ’24 to sell 5946.0 shares. Meanwhile, Chairman & CEO Cordani David sold 31209.0 shares on Mar 25 ’24.
